Skip to content

Investigating the effect of ferrous sulfate on thyroid function in pregnant women

Investigating the effect of ferrous sulfate on thyroid function in pregnant women with acquired hypothyroidism in the second trimester of pregnancy

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240211060962N1
Enrollment
48
Registered
2024-06-01
Start date
2024-04-20
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary acquired hypothyroidism. Other iodine-deficiency related thyroid disorders and allied conditions

Interventions

Intervention 1: Intervention group: At the beginning of the study, 5 cc of blood will be collected from each patient and for testing, it will be done using vidas kits for ferritin and thyroid hormones

Sponsors

Oroumia University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: Age 20 to 35 years Second trimester pregnancy is considered Primary acquired thyroid disease Obtaining informed consent and explanation to patients The bmi of pregnant mothers is considered within the normal range (18.5-24.5)

Exclusion criteria

Exclusion criteria: Having diabetes and high blood pressure Suffering from chronic diseases, including chronic kidney failure and liver failure Getting cancer and neoplasm, especially thyroid cancer Dissatisfaction of patients

Design outcomes

Primary

MeasureTime frame
Primary outcome variable: pregnant women with primary acquired hypothyroidism or those whose tsh is greater than 4.5 mlU/L. Timepoint: Measurement of thyroid hormones at the beginning of the intervention (before the start) and 2 months after the start of ferrous sulfate. Method of measurement: The method of measurement is through laboratory tests, 5 cc of blood will be taken from each patient, and for the test, vidas kits for thyroid hormones will be taken.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMobina Pourghahramani

Oroumia University of Medical Sciences

pourmobinaaa97@gmail.com+98 44 3346 8815

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026